Gefitinib-induced disseminated intravascular coagulation in a patient with non-small cell lung cancer
In February 2005, Gefitinib (Iressa), a small-molecular .epidermal growth factor receptor and tyrosine kinaseinhibitor, was approved in China as an anticancer agent for patients with advanced (local or metastatic) non-small cell lung cancer (NSCLC), who failed prior chemotherapy. The common adverse...
Saved in:
Published in | Chinese medical journal Vol. 123; no. 4; pp. 505 - 506 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
China
Cancer Center, 82nd Hospital of the Chinese People's Liberation Army, Huai'an, Jiangsu 223001, China%Department of Oncology, First People's Hospital of Jingzhou,Jingzhou, Hubei 434000, China%Cancer Center, Renmin Hospital of Wuhan University, Wuhan,Hubei 430060, China
20.02.2010
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!